Cocrystal Pharma (COCP) Gross Profit (2010 - 2013)

Cocrystal Pharma (COCP) has 4 years of Gross Profit data on file, last reported at $551698.0 in Q2 2013.

• For the quarter ending Q2 2013, Gross Profit fell 72.83% year-over-year to $551698.0; the trailing twelve-month figure through Jun 2013 stood at $4.9 million (up 8.2% YoY), and the FY2012 full-year result was $7.2 million, up 168.9% from the prior year.
• Gross Profit eased to $551698.0 in Q2 2013, from $592083.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $2.1 million in Q3 2010 to a low of -$1.0 million in Q4 2011.
• A 4-year average of $1.3 million and a median of $1.4 million in 2012 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit plunged 183.52% in 2011 and jumped 265.33% in 2012, its largest moves.
• Tracing COCP's Gross Profit over 4 years: stood at $1.2 million in 2010, then slumped by 183.52% to -$1.0 million in 2011, then jumped by 265.33% to $1.7 million in 2012, then slumped by 67.99% to $551698.0 in 2013.
• Business Quant data shows COCP's Gross Profit at $551698.0 in Q2 2013, $592083.0 in Q1 2013, and $1.7 million in Q4 2012.